TLR4 and hepatocellular carcinoma: LPS is able to augment TNF-α production and activate the toll-like receptor 4 (TLR-4) pathway, thereby inducing a hepatic inflammatory response, leading to the progression of liver fibrosis and HCC (87, 88).